Haslina Ahmad1*, Nur Izzah Md Fadhilah2, Mohd Basyaruddin Abdul Rahman1, Loqman Mohamad Yusof3
1. Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
2. Department of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia
3. Department of Companion Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia
*Corresponding author: Haslina Ahmad.
ABSTRACT
INTRODUCTION: The treatment of full-thickness skin wounds and burns remains a major clinical hurdle. Short bioactive peptides represent a novel class of therapeutic agents capable of promoting tissue regeneration by activating intrinsic wound healing mechanisms. Accordingly, the design of peptide-based biomaterials for skin repair is gaining increasing attention in regenerative medicine research.
OBJECTIVE(S): This study evaluates the in vivo wound healing efficacy of a novel fatty acid-conjugated tetrapeptide, Palmitoyl-GDPH (Palmitic acid–Glycine–Aspartic acid–Proline–Histidine), in a full-thickness excision wound model in rats. The selection of Palmitoyl-GDPH was guided by its previously demonstrated ability to stimulate proliferation and migration in normal human dermal fibroblasts (NHDF), indicating its potential as a therapeutic candidate for skin repair. Structurally, Palmitoyl-GDPH was rationally designed as a derivative of Palmitoyl tetrapeptide-7 (Palmitoyl-GQPR), the active peptide in the commercial product RIGIN™ (SEDERMA), with modifications intended to enhance its regenerative properties.
MATERIALS & METHODS: A 4 cm² full-thickness excisional wound was surgically created on the dorsum of Sprague Dawley rats, followed by topical application of Palmitoyl-GDPH in liquid formulation. Tetracycline was used as the standard comparator due to its recognized wound healing and antimicrobial efficacy. Healing outcomes were analyzed through histological and hematological evaluations.
RESULTS: Palmitoyl-GDPH exhibited significant wound healing activity in a Sprague Dawley rat model of full-thickness skin injury. Following 18 days of topical administration, histological assessments revealed near-complete wound closure, marked by accelerated re-epithelialization, enhanced collagen deposition, and minimal scar formation compared to controls. Importantly, the restoration of a well-defined epidermal-dermal junction, along with the induction of new hair follicle formation, indicated regeneration of structurally and functionally viable skin tissue. Hematological analyses further corroborated these findings, showing reduced inflammatory markers consistent with faster wound resolution and improved recovery in the Palmitoyl-GDPH-treated group.
CONCLUSION: The demonstrated efficacy of Palmitoyl-GDPH suggests its potential application as a next-generation wound healing agent.
KEYWORDS: Short Peptide, Tetrapeptide, Wound Healing, Full-thickness Skin Wounds


